Deleted genes in the region including WT1 and PAX6 are thought to cause the phenotypic features and clinical issues in patients; however, much is still unknown about the specific molecular role of these genes in patients with WAGR syndrome. This evidence concerns the gene WT1 and WAGR syndrome.